Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.590
-0.180 (-6.50%)
At close: Jul 1, 2025, 4:00 PM
2.562
-0.028 (-1.09%)
After-hours: Jul 1, 2025, 6:31 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $97.57 million as of July 1, 2025. Its market cap has decreased by -62.83% in one year.
Market Cap
97.57M
Enterprise Value
-9.28M
1-Year Change
-62.83%
Ranking
Category
Stock Price
$2.59
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $97.57M, a decrease of -80.01%. That is a compound annual growth rate of -33.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2025 | 97.57M | -64.51% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.09B |
| Johnson & Johnson | 364.98B |
| AbbVie | 325.51B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 282.35B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 235.40B |
| AstraZeneca | 215.00B |